CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...